Abstract
Routine hematoxylin and eosin-stained sections are often appropriate and adequate for the definite diagnosis of pathological lesions. However, in cases where light microscopic examination of tissue sections from biopsy and surgical specimens is inconclusive, immunohistochemistry can efficiently back up histopathology. Albert H. Coons was the first who used a specific antibody to localize pneumococcal antigen in tissues (Coons et al. 1941, 1942). Since that time, the use of antibodies to detect individual antigens in situ has developed into a powerful diagnostic tool. With the broad availability of immunological markers, immunohistochemistry is becoming increasingly indispensable in pathology and in diagnostic pathology of different organ systems. At present, most of the antigens are easily detected both in formalin-fixed paraffin-embedded tissue samples and in ethanol-fixed cytological smears. Over the past 20 years, immunohistochemical and immunocytological stains have therefore become an integral part of routine diagnostic procedures in difficult cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203:661–671
Altmannsberger M, Dirk T, Droese M, Weber K, Osborn M (1986) Keratin polypeptide distribution in benign and malignant breast tumors: subdivision of ductal carcinomas using monoclonal antibodies. Virchows Arch B Cell Pathol Incl Mol Pathol 51(3):265–275
Assefnia S, Jones LP, Torre KM, Furth PA (2006) Expression of p63 in a mouse model of Brca1-mutation-related breast cancer. Poster presented at the Annual Meeting of the American Association for Cancer Research, Washington, DC (Meeting Abstracts)
Bártek J, Vojtěsek B, Stasková Z, Bártková J, Kerekés Z, Rejthar A, Kovarík J (1991) A series of 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology. J Pathol 164(3):215–224
Battifora H (1986) The multitumor (sausage) tissue block – novel method for immunohistochemical antibody testing. Lab Invest 55:244–248
Böcker W, Moll R, Poremba C, Holland R, Van Diest PJ, Dervan P, Burger H, Wai D, Ina DR, Brandt B, Herbst H, Schmidt A, Lerch MM, Buchwalow IB (2002) Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest 82(6):737–746
Böcker W et al (2006) Preneoplasia of the breast: a new conceptual approach to proliferative breast disease. Elsevier, Münich
Chu PG, Weiss LM (2002a) Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol 15(1):6–10
Chu PG, Weiss LM (2002b) Keratin expression in human tissues and neoplasms. Histopathology 40(5):403–439
Coons AH, Creech H, Jones R (1941) Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med 47:200–202
Coons AH, Creech H, Jones R, Berliner E (1942) The demonstration of pneumococcal antigen in tissues by the use of fluorescent antibody. J Immunol 45:159–170
Dabbs DJ (ed) (2006) Diagnostic immunohistochemistry. Churchill Livingstone, Philadelphia
Dairkee SH, Mayall BH, Smith HS, Hackett AJ (1987) Monoclonal marker that predicts early recurrence of breast cancer. Lancet 1(8531):514
Demirkesen C, Hoede N, Moll R (1995) Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins. J Cutan Pathol 22(6):518–535
Diaz LK, Cryns VL, Symmans WF, Sneige N (2007) Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice. Adv Anat Pathol 14(6):419–430
Fillies T, Werkmeister R, Packeisen J, Brandt B, Morin P, Weingart D, Joos U, Buerger H (2006) Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer 6:10
Foschini MP, Scarpellini F, Gown AM (2000) Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol 8:29–37
Franke WW, Schiller DL, Moll R, Winter S, Schmid E, Engelbrecht I, Denk H, Krepler R, Platzer B (1981) Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol 153(4):933–959
Fuchs E, Green H (1980) Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 19(4):1033–1042
Gusterson BA, Ross DT, Heath VJ, Stein T (2005) Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Breast Cancer Res 7(4):143–148
Hsu FD, Nielsen TO, Alkushi A, Dupuis B, Huntsman D, Liu CL, van de Rijn M, Gilks CB (2002) Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 15:1374–1380
Ivanyi D, Ansink A, Groeneveld E, Hageman PC, Mooi WJ, Heintz AP (1989) New monoclonal antibodies recognizing epidermal differentiation-associated keratins in formalin-fixed, paraffin-embedded tissue. Keratin 10 expression in carcinoma of the vulva. J Pathol 159(1):7–12
Jacquemier J, Padovani L, Rabayrol L, Lakhani SR, Penault-Llorca F, Denoux Y, Fiche M, Figueiro P, Maisongrosse V, Ledoussal V, Martinez PJ, Udvarhely N, El MG, Ginestier C, Geneix J, Charafe-Jauffret E, Xerri L, Eisinger F, Birnbaum D, Sobol H (2005) Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol 207:260–268
Jetten AM, Harvat BL (1997) Epidermal differentiation and squamous metaplasia: from stem cell to cell death. J Dermatol 24:711–725
Kalof AN, Tam D, Beatty B, Cooper K (2004) Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain. J Clin Pathol 57:625–629
Kononen J, Bubendorf L, Kallionimeni A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallionimeni OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847
Kraaz W, Risberg B, Hussein A (1988) Multiblock – an aid in diagnostic immunohistochemistry. J Clinic Pathol 41:1337
Lobeck H, Bartke I, Naujoks K, Müller D, Bornhöft G, Mischke D, Wild G (1989) Verteilungsmuster der Zytokeratinpolypeptide 4 und 5 im normalen und neoplastischen Epithel unter Verwendung neuer paraffingängiger monoklonaler Antikörper (eine immunhistochemische Untersuchung). Verh Dtsch Ges Pathol 73:645
Malzahn K, Mitze M, Thoenes M, Moll R (1998) Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch 433(2):119–129
Moch H, Kononen J, Kallioniemi OP, Sauter G (2001) Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv Anat Pathol 8:14–20
Moll R (1998) Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem 31:205–262
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982a) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31(1):11–24
Moll R, Franke WW, Volc-Platzer B, Krepler R (1982b) Different keratin polypeptides in epidermis and other epithelia of human skin: a specific cytokeratin of molecular weight 46,000 in epithelia of the pilosebaceous tract and basal cell epitheliomas. J Cell Biol 95(1):285–295
Moll R, Krepler R, Franke WW (1983) Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 23(3):256–269
Moll R, Dhouailly D, Sun TT (1989) Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE14. Virchows Arch B Cell Pathol Incl Mol Pathol 58(2):129–145
Moll R, Schiller DL, Franke WW (1990) Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 111(2):567–580
Moll R, Löwe A, Laufer J, Franke WW (1992) Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427–447
Moll R, Divo M, Langbein L (2008) The human keratins: biology and pathology. Histochem Cell Biol 129:705–733
Moritani S, Kushima R, Sugihara H et al (2002) Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol 15:397–405
Narahashi T, Niki T, Wang T, Goto A, Matsubara D, Funata N, Fukayama M (2006) Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma. Histopathology 49(4):349–357
Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Böcker W (2000) Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 37(3):232–240
Owens DW, Lane EB (2003) The quest for the function of simple epithelial keratins. Bioessays 25(8):748–758
Pia-Foschini M, Reis-Filho JS, Eusebi V, Lakhani SR (2003) Salivary gland-like tumours of the breast: surgical and molecular pathology. J Clin Pathol 56:497–506
Purkis PE, Steel JB, Mackenzie IC, Nathrath WB, Leigh IM, Lane EB (1990) Antibody markers of basal cells in complex epithelia. J Cell Sci 97(Pt 1):39–50
Reis-Filho JS, Tutt AN (2008) Triple negative tumours: a critical review. Histopathology 52:108–118
Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DA, Rogers MA, Wright MW (2006) New consensus nomenclature for mammalian keratins. J Cell Biol 174(2):169–174
Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de RM, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874
Troyanovsky SM, Guelstein VI, Tchipysheva TA, Krutovskikh VA, Bannikov GA (1989) Patterns of expression of keratin 17 in human epithelia: dependency on cell position. J Cell Sci 93(Pt 3):419–426
Troyanovsky SM, Leube RE, Franke WW (1992) Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol 59(1):127–137
van de Rijn RM, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, Kochli OR, Mross F, Dieterich H, Seitz R, Ross D, Botstein D, Brown P (2002) Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 161(6):1991–1996
Wetzels RH, Kuijpers HJ, Lane EB, Leigh IM, Troyanovsky SM, Holland R, van Haelst UJ, Ramaekers FC (1991) Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol 138(3):751–763
Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V et al (1998) p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305–316
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Buchwalow, I.B., Böcker, W. (2010). Diagnostic Immunohistochemistry. In: Immunohistochemistry: Basics and Methods. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04609-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-04609-4_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-04608-7
Online ISBN: 978-3-642-04609-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)